Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2009-07-21 20:26:26 UTC |
---|
Update Date | 2016-11-09 01:08:41 UTC |
---|
Accession Number | CHEM002156 |
---|
Identification |
---|
Common Name | Ropinirole |
---|
Class | Small Molecule |
---|
Description | Ropinirole is a non-ergoline dopamine agonist, manufactured by GlaxoSmithKline. It is used in the treatment of Parkinson's disease, and is also one of two medications in the United States with an FDA-approved indication for the treatment of restless legs syndrome (the other being Pramipexole). |
---|
Contaminant Sources | - HMDB Contaminants - Urine
- STOFF IDENT Compounds
- T3DB toxins
- ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | - Amide
- Amine
- Antidyskinetic
- Antiparkinson Agent
- Central Nervous System Agent
- Dopamine Agonist
- Drug
- Metabolite
- Organic Compound
- Synthetic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
Ropinirol | ChEBI | Ropinirolum | ChEBI | Ropitor | Kegg | 4-(2-(Di-N-propylamino)ethyl)-2(3H)-indolone | HMDB | GlaxoSmithKline brand OF ropinirole hydrochloride | HMDB | Requip | HMDB | SK And F-101,468 | HMDB | SmithKline beecham brand OF ropinirole hydrochloride | HMDB | Ropinirole hydrochloride | HMDB | SK And F 101468 | HMDB |
|
---|
Chemical Formula | C16H24N2O |
---|
Average Molecular Mass | 260.375 g/mol |
---|
Monoisotopic Mass | 260.189 g/mol |
---|
CAS Registry Number | 91374-21-9 |
---|
IUPAC Name | 4-[2-(dipropylamino)ethyl]-2,3-dihydro-1H-indol-2-one |
---|
Traditional Name | ropinirole |
---|
SMILES | CCCN(CCC)CCC1=C2CC(O)=NC2=CC=C1 |
---|
InChI Identifier | InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19) |
---|
InChI Key | InChIKey=UHSKFQJFRQCDBE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as indolines. Indolines are compounds containing an indole moiety, which consists of pyrrolidine ring fused to benzene to form 2,3-dihydroindole. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Indolines |
---|
Direct Parent | Indolines |
---|
Alternative Parents | |
---|
Substituents | - Dihydroindole
- Phenethylamine
- Aralkylamine
- Benzenoid
- Amino acid or derivatives
- Carboxamide group
- Lactam
- Secondary carboxylic acid amide
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid derivative
- Azacycle
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane
|
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | White powder. |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 243-250°C | Boiling Point | Not Available | Solubility | 133 mg/mL |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-03kd-8950000000-65ad14635cd7e9f25153 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 50V, Positive | splash10-001i-0900000000-fd0720d43d850f7b4112 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 30V, Positive | splash10-03e9-0900000000-0cffe19378ee7388c9b3 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 40V, Positive | splash10-001i-0900000000-7b58f2b7d78649e5141a | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0390000000-844dec8f945ae2bdddcd | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0090000000-8c7df92a90c013ff6e26 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0190000000-7e072cf65f341641938c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-3960000000-47d2311adfeeacf4062d | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-7900000000-0891c66db163729a5360 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0090000000-88c0fa3d93090a0d06c6 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0pb9-3590000000-8fb5fc766313ee6bbd9e | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0k96-9400000000-f1b50dacd59a9bfe90b7 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0190000000-bfa59f1f4dd92796c2f1 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-1970000000-134d3ee14c868165c82d | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-01pp-7900000000-2459901fcec4348b7dbc | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0090000000-7c4aa654b272455d2904 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0590000000-4395944c67ba02f5a73b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-053r-2900000000-2cb3b5572e758c0d2eb0 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral.
Absolute bioavailability is 55%, indicating a first pass effect. Food does not affect the extent of absorption. |
---|
Mechanism of Toxicity | Ropinirole binds the dopamine receptors D3 and D2. Although the precise mechanism of action of ropinirole as a treatment for Parkinson's disease is unknown, it is believed to be related to its ability to stimulate these receptors in the striatum. This conclusion is supported by electrophysiologic studies in animals that have demonstrated that ropinirole influences striatal neuronal firing rates via activation of dopamine receptors in the striatum and the substantia nigra, the site of neurons that send projections to the striatum. |
---|
Metabolism | Hepatic. Ropinirole is extensively metabolized to inactive metabolites via N -despropylation and hydroxylation pathways, largely by the P450 isoenzyme CYP1A2. N-despropyl ropinirole is the predominant metabolite found in urine (40%), followed by the carboxylic acid metabolite (10%), and the glucuronide of the hydroxy metabolite (10%).
Route of Elimination: Ropinirole is extensively metabolized by the liver to inactive metabolites, and less than 10% of the administered dose is excreted as unchanged drug in urine.
Half Life: 6 hours |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | For the treatment of the signs and symptoms of idiopathic Parkinson's disease. Also used for the treatment of restless legs syndrome. |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Symptoms of overdose include agitation, chest pain, confusion, drowsiness, facial muscle movements, grogginess, increased jerkiness of movement, symptoms of low blood pressure (dizziness, light-headedness)upon standing, nausea, and vomiting. |
---|
Treatment | General supportive measures are recommended. Vital signs should be maintained, if necessary. Removal of any unabsorbed material (e.g., by gastric lavage) should be considered. (2) |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB00268 |
---|
HMDB ID | HMDB0014413 |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Ropinirole |
---|
Chemspider ID | 4916 |
---|
ChEBI ID | 8888 |
---|
PubChem Compound ID | 5095 |
---|
Kegg Compound ID | C07564 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | DrugSyn.org |
---|
MSDS | Link |
---|
General References | Not Available |
---|